Friday 16 October 2026
Export AVXL’s income statement to Excel — free account
Anavex Life Sciences Corp.
AVXL Healthcare Biotechnology
In the quarter to June 2026, EPS grew 150.0% and free cash flow grew 27.0%, each against the same quarter a year earlier.
1.31
0.17
−11.49%
Follow AVXL
| Sep '25 | Sep '24 | Sep '23 | Sep '22 | Sep '21 | Sep '20 | Sep '19 | Sep '18 | Sep '17 | Sep '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
11.60 | 8.86 | 12.32 | 14.95 | 14.97 | 4.73 | 5.03 | 6.71 | 7.75 | 2.96 |
Net Debt/EBITDA |
2.00 | 2.50 | 2.71 | 2.93 | 3.62 | 0.94 | 0.77 | 1.19 | 1.75 | 0.59 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.84 | 0.72 | 0.58 | 0.51 | 0.80 | 0.81 | 0.70 | 0.73 | 0.67 | 0.63 |
Capex/Depreciation |
— | — | — | — | — | — | 0.00 | — | — | 0.00 |
| (43.11%) | (32.81%) | (33.41%) | (32.71%) | (42.58%) | (110.59%) | (123.42%) | (74.08%) | (88.09%) | (154.17%) | |
| (38.75%) | (29.66%) | (30.94%) | (30.53%) | (38.65%) | (87.79%) | (102.05%) | (63.85%) | (72.10%) | (118.04%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(48.89%) | (35.76%) | (33.49%) | (33.67%) | (25.14%) | (96.49%) | (129.60%) | (77.83%) | (55.62%) | (235.57%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.46) | (0.37) | (0.35) | (0.32) | (0.44) | (0.37) | (0.38) | (0.28) | (0.22) | (0.26) |
Cash per Share |
1.20 | 1.58 | 1.89 | 1.94 | 2.18 | 0.50 | 0.45 | 0.51 | 0.67 | 0.26 |
Shareholders Equity per Share |
1.11 | 1.44 | 1.78 | 1.85 | 2.16 | 0.47 | 0.41 | 0.50 | 0.59 | 0.18 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.11 | 1.44 | 1.78 | 1.85 | 2.16 | 0.47 | 0.41 | 0.50 | 0.59 | 0.18 |
Free Cash Flow |
(39.04) | (30.81) | (27.78) | (24.24) | (30.38) | (21.29) | (18.53) | (12.58) | (9.02) | (9.24) |
Working Capital |
94.87 | 120.26 | 141.85 | 142.49 | 150.82 | 27.24 | 20.29 | 22.17 | 24.20 | 6.26 |
Net Current Asset Value |
94.87 | 120.26 | 141.85 | 142.49 | 150.82 | 27.24 | 20.29 | 22.17 | 24.20 | 6.26 |
| Other line items | ||||||||||
Quick Ratio |
11.56 | 8.80 | 12.27 | 14.92 | 14.93 | 4.67 | 4.93 | 6.38 | 7.66 | 2.90 |
Depreciation/Fixed assets |
— | — | — | — | — | — | 0.00 | — | — | 0.00 |
Cash ROIC |
(19.77%) | (12.21%) | (9.49%) | (8.31%) | (10.03%) | (37.69%) | (43.62%) | (27.80%) | (17.44%) | (59.61%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | — | — | — | — | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | — | — | — | — | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.46) | (0.37) | (0.35) | (0.32) | (0.44) | (0.37) | (0.38) | (0.28) | (0.22) | (0.26) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
1.63 | 2.58 | 2.95 | 6.16 | 6.99 | 3.75 | 2.26 | 0.94 | 0.04 | 0.08 |
Average Payables |
6.94 | 6.97 | 4.07 | 4.28 | 4.36 | 3.76 | 3.24 | 3.27 | 3.35 | 2.81 |
Average Assets |
119.69 | 144.98 | 153.55 | 157.16 | 98.08 | 29.94 | 25.77 | 27.02 | 18.67 | 12.48 |
Average Common Equity |
107.57 | 131.06 | 142.17 | 146.65 | 89.03 | 23.76 | 21.31 | 23.29 | 15.28 | 9.56 |
Columns are period end dates